Literature DB >> 34019337

American Indian and Alaska Native Enrollment in Clinical Studies in the National Institutes of Health's Intramural Research Program.

Deionna Vigil1, Ninet Sinaii2, Barbara Karp3.   

Abstract

Clinical studies conducted by the National Institutes of Health's Intramural Research Program (NIH-IRP) provide eligible individuals with access to innovative research treatments that may not otherwise be available. The NIH-IRP's mission is to include all Americans, including American Indians and Alaska Natives, in its clinical research. This study is the first to provide data about inclusion of American Indians/Alaska Natives in NIH-IRP clinical studies. We analyzed data from the more than 1,800 NIH-IRP protocols active in 2014 and 2017. We found that the absolute number of American Indian/Alaska Native enrollees increased between 2014 and 2017 but remained at 1% of all participants, a disproportionately low level. The number of clinical studies that enrolled American Indian/Alaska Native individuals similarly did not change. NIH efforts to expand participation of American Indians/Alaska Natives in clinical studies has often focused on research within their communities or on health needs specific to these groups. Those efforts should expand to include processes and protections for the proportionate and ethical inclusion of American Indians and Alaska Natives who individually enroll in studies that are not specific to American Indians, Alaska Natives, or their tribal nations.
© 2021 by The Hastings Center. All rights reserved.

Entities:  

Keywords:  Alaska Native participation in research; American Indian participation in research; National Institutes of Health; clinical studies; clinical trials; human research ethics; human subjects research

Year:  2021        PMID: 34019337     DOI: 10.1002/eahr.500090

Source DB:  PubMed          Journal:  Ethics Hum Res        ISSN: 2578-2355


  4 in total

1.  Ethnic/racial and gender differences in disordered eating behavior prevalence trajectories among women and men from adolescence into adulthood.

Authors:  Melissa Simone; Susan Telke; Lisa M Anderson; Marla Eisenberg; Dianne Neumark-Sztainer
Journal:  Soc Sci Med       Date:  2022-01-11       Impact factor: 4.634

Review 2.  Psychedelic Therapies at the Crossroads of Trauma and Substance Use: Historical Perspectives and Future Directions, Taking a Lead From New Mexico.

Authors:  Snehal R Bhatt; Maya Armstrong; Tassy Parker; Marcello Maviglia; Rebecca Kass; Lawrence Leeman; Paul Romo; Douglas Ziedonis
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

Review 3.  Designing Inclusive HPV Cancer Vaccines and Increasing Uptake among Native Americans-A Cultural Perspective Review.

Authors:  Skyler J Bordeaux; Anthony W Baca; Rene L Begay; Francine C Gachupin; J Gregory Caporaso; Melissa M Herbst-Kralovetz; Naomi R Lee
Journal:  Curr Oncol       Date:  2021-09-24       Impact factor: 3.109

4.  The representation of Indigenous peoples in chronic disease clinical trials in Australia, Canada, New Zealand, and the United States.

Authors:  Valerie Umaefulam; Tessa Kleissen; Cheryl Barnabe
Journal:  Clin Trials       Date:  2022-01-06       Impact factor: 2.486

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.